Jinhe Biotechnology CO., LTD.

¥4.67As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002688Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (6.68%)
Div yield 2.14%
ROE (0.38%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.40
PE TTM 169.8
TSR TTM (24.51%)
Mkt cap ¥3.529B
ROIC (1.24%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥5.91
26.63%
(34.32%)
Hold 10|2|9|9|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.09
0.10
0.10
0.10
11.70%
30.31%
28.93%
24.32%
Revenue¥M
233.6
244.7
255.3
254.8
1.22%
4.16%
11.83%
12.84%
Peers (US$529.0M)
Cap (US$)
PE
534.0M
18.71x
524.0M
31.37x
529.1M
5.939x
Capital
TTM
5Y
10Y
Leveragex
0.360
0.153
0.136
EBIT/Intx
1.094
1.124
1.091
Own earn%
(98.89)
(5.48)
(0.64)
Sh yield%
14.27
11.65
12.30
Owners
Insiders/Inst%
0.57
77.36
Short interest%
2.03
SBC / revenue%
4.00
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
31–41
$1 testx
0.6
Incr. ROIC%
4